ClinicalTrialsFinder

Head and Neck Cancers Nasopharynx Clinical Trials in Washington D.C., District of Columbia

1 recruitingWashington D.C., District of Columbia

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Esophageal CancerPancreatic CancerHead and Neck Squamous Cell Carcinoma (HNSCC)+22 more
VM Oncology, LLC242 enrolled15 locationsNCT03556228